The HbA1c test measures how much glucose has attached itself to hemoglobin, the oxygen-carrying protein inside red blood cells, over the previous two to three months. Because red blood cells circulate for roughly 120 days before being recycled, the percentage of hemoglobin that has been “sugar-coated” serves as a running average of blood sugar rather than a single snapshot. The connection between elevated HbA1c and diabetes was first identified in 1969, and the test has since become the standard tool for diagnosing and monitoring both type 2 and type 1 diabetes.1PubMed. Haemoglobin A1c: Historical overview and current concepts Understanding what the test captures, where it falls short, and how it fits alongside newer tools gives you a much clearer picture of what your result actually means.
How Glucose Sticks to Hemoglobin
The process behind HbA1c is called glycation. Glucose molecules floating in the bloodstream spontaneously latch onto free amine groups on the hemoglobin protein, forming a stable bond. No enzyme drives the reaction; it happens passively whenever glucose and hemoglobin are in contact.2PubMed. Structural changes in hemoglobin and glycation The higher your blood sugar runs over weeks and months, the more hemoglobin molecules end up glycated. By measuring that fraction, a lab can estimate how much glucose has been circulating without needing you to fast or drink a sugary solution beforehand.
This is what makes HbA1c fundamentally different from a fasting blood glucose reading or an oral glucose tolerance test. Those tests capture what is happening at a single moment. HbA1c integrates the entire history of your blood sugar from the time a red blood cell was born in the bone marrow until the day your blood was drawn. It is weighted toward the most recent four to six weeks, since newer red blood cells have had more time to accumulate glucose while older ones are being cleared, but the overall window is about two to three months.
What the Numbers Mean
Clinicians use three broad ranges when interpreting HbA1c. A result below 5.7% is considered normal. Between 5.7% and 6.4% falls into the prediabetes range, signaling that blood sugar has been running higher than ideal and the risk of progressing to diabetes is elevated. An HbA1c of 6.5% or above is the diagnostic threshold for diabetes. These cutoffs were originally anchored to the risk of retinopathy, and a recent study confirmed that the 6.5% mark does not need to be adjusted to accommodate kidney-disease risk either.3PubMed. Using nephropathy as an outcome to determine the HbA1c diagnostic threshold for type 2 diabetes
That said, these cutoffs are not perfect detectors. When researchers compared HbA1c-based diagnoses to diagnoses based on fasting glucose and a two-hour glucose tolerance test, the HbA1c thresholds caught a relatively small share of cases. The 6.5% cutoff for diabetes had a sensitivity of only about 25%, meaning roughly three-quarters of people who would be diagnosed by blood glucose testing were missed by HbA1c alone. For prediabetes at 5.7%, sensitivity was about 35%.4PubMed Central. Use of HbA1c for Diagnoses of Diabetes and Prediabetes: Comparison with Diagnoses Based on Fasting and 2-Hr Glucose Values and Effects of Gender, Race, and Age The trade-off is high specificity: if your HbA1c does cross the threshold, the diagnosis is very likely correct. The test is better at confirming diabetes than at ruling it out, which is why clinicians sometimes pair it with a fasting glucose test when the clinical picture is unclear.
In children and adolescents, the optimal cutoffs may differ slightly. One study of obese young people found that an HbA1c of 5.8% worked best for identifying prediabetes and 6.2% for diabetes, both a bit higher than adult screening norms for prediabetes and a bit lower for diabetes.5PubMed Central. HbA1c Cutoff for Prediabetes and Diabetes Based on Oral Glucose Tolerance Test in Obese Children and Adolescents This underscores that a single set of numbers does not fit every population equally well.
When HbA1c Can Mislead You
The test assumes your red blood cells live a normal lifespan and that your hemoglobin behaves in a standard way. Several common conditions violate those assumptions, pushing your result higher or lower than your actual blood sugar warrants.
Iron deficiency anemia is one of the most widespread confounders. The direction of the distortion, though, depends on the study. One study found that iron-deficient patients had a mean HbA1c of about 4.6% compared with 5.5% in controls, and that HbA1c rose after iron treatment.6PubMed Central. Effect of iron deficiency anemia on hemoglobin A1c levels Another study found the opposite pattern: iron-deficient patients averaged 5.75% versus 5.32% in controls, and their HbA1c dropped to 5.44% after treatment.7PubMed Central. The effect of different types of anemia on HbA1c levels in non-diabetics The inconsistency likely reflects differences in severity, the stage of iron depletion, and the lab method used. The practical takeaway is that if you are anemic, your HbA1c may not be a reliable stand-in for average glucose in either direction.
Hemoglobin variants create a different kind of problem. People who carry the sickle cell trait (HbAS) can get dramatically wrong results depending on how the lab measures HbA1c. One analysis found that certain chromatography-based methods introduced a negative bias of around 39% to 41%, meaning an HbA1c that should have read 6.5% might come back near 4%. Immunoassay methods fared better, with biases of only about 2% to 6%.8PubMed Central. Major Discordance in Hemoglobin A1c Measurement in Sickle Cell Trait: Effect of Analytical Methods Because the sickle-cell gene alters the electrical charge and shape of the hemoglobin molecule, it can throw off the separation step that some lab instruments rely on. If you carry a known hemoglobin variant, your clinician should confirm which assay method was used and whether it is certified to work accurately with that variant.
Chronic kidney disease has long been suspected of skewing results because it shortens red blood cell survival and produces carbamylated hemoglobin, which some instruments confuse with glycated hemoglobin. However, a study evaluating several modern instruments found that none showed clinically significant interference from reduced kidney function, even though tiny statistical differences existed.9PubMed Central. Measurement of HbA1c in patients with chronic renal failure With current-generation assays, kidney disease is less of a practical concern than it once was, though clinicians in specialized settings may still supplement HbA1c with other glucose markers.
Pregnancy and HbA1c
Pregnancy reshapes the blood in ways that push HbA1c downward. Plasma volume expands faster than red blood cell production, diluting hemoglobin concentration. Red cell turnover increases, meaning hemoglobin spends less time exposed to glucose before being recycled. These physiological shifts lower HbA1c enough that pregnancy-specific reference ranges may be needed.10PubMed. Is There a Role for HbA1c in Pregnancy?
Despite the lower absolute levels, HbA1c still tracks with average glucose during pregnancy. In one study, each 1 percentage-point difference in HbA1c corresponded to roughly a 0.67 mmol/L difference in average glucose.11PubMed Central. Translating HbA(1c) measurements into estimated average glucose values in pregnant women with diabetes The relationship holds, but the scale shifts. That is why many obstetric guidelines recommend tighter HbA1c targets during pregnancy, and why clinicians often rely more on frequent self-monitoring or continuous glucose monitors alongside HbA1c for pregnant patients with diabetes.
Racial and Ethnic Differences
One of the more contentious aspects of HbA1c is that it does not always map to blood sugar the same way across racial and ethnic groups. Across two large studies, Black participants had HbA1c levels that were 0.13 to 0.21 percentage points higher than those of white participants with the same glucose tolerance status, even after adjusting for actual plasma glucose levels and other characteristics. The gap widened at higher glucose levels: among people with diabetes, the difference averaged about 0.47 percentage points.12PubMed. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies
The reasons remain unclear. Differences in red blood cell lifespan, the way glucose moves between the bloodstream and the interior of red cells, and non-glycemic genetic factors that influence the rate of hemoglobin glycation are all under investigation.13PubMed Central. Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes Although researchers have confirmed that statistically different regression lines exist between groups, there is also substantial overlap between individuals, meaning the group-level difference cannot be simply applied as a correction factor for any single patient.14The Journal of Clinical Endocrinology & Metabolism. When HbA1c and Blood Glucose Do Not Match: How Much Is Determined by Race, by Genetics, by Differences in Mean Red Blood Cell Age? In practice, this means that relying solely on HbA1c cutoffs for diagnosis or treatment decisions can systematically over- or under-identify diabetes in certain populations.
How the Lab Actually Runs the Test
Multiple laboratory methods exist for measuring HbA1c, and they do not always return the same number. The most common approaches are high-performance liquid chromatography (HPLC), immunoassays, and enzymatic assays. International standardization efforts have brought these methods into closer agreement than they were decades ago, when substantial inter-laboratory and inter-instrument differences were a routine headache.15Diabetes Research and Clinical Practice. Standardization of HbA1c value and its comparison to immunoassay — two years of experience
Still, differences persist. A comparison of two HPLC instruments from different labs found a mean difference of about 2% to 3% between them, and HPLC and immunoassay methods could not be used interchangeably without affecting patient classification around diagnostic cutoffs.16Journal of Health Sciences and Medicine. Comparison of high performance liquid chromatography and turbidimetric inhibition immunoassay methods for measurement of hemoglobin A1c Off-site health checkups using immunoassay or enzymatic kits have also shown readings that are systematically slightly lower than on-site HPLC results from the same blood samples.17PubMed Central. HbA1c levels Measured by Enzymatic Assay and Immunoassay during Off-Site Health Checkups Are Both Lower than Those Measured by On-Site HPLC Assay These differences are generally small for most patients, but at diagnostic boundaries like 6.4% versus 6.5%, even a 0.1% shift could change whether someone receives a diabetes diagnosis.
Point-of-care (POC) devices that give results in minutes at a clinic or pharmacy have improved considerably. One evaluation of a POC system found it correlated almost perfectly with the reference laboratory method, with an average bias of only about 0.02 percentage points for fingerstick samples.18PubMed Central. Accuracy and Precision of a Point-of-Care HbA1c Test A study in Indonesia found that POC HbA1c had high sensitivity (about 98%) for detecting diabetes compared with a standard lab, though specificity was lower at around 77%, meaning some false positives crept in among non-diabetic individuals.19PubMed Central. Performance of Point-of-Care Testing Compared with the Standard Laboratory Diagnostic Test in the Measurement of HbA1c in Indonesian Diabetic and Nondiabetic Subjects For routine monitoring rather than initial diagnosis, POC testing is convenient and reasonably accurate, but confirming a new diabetes diagnosis still typically calls for a standard lab draw.
HbA1c Targets for Older Adults
Most adults with diabetes are encouraged to aim for an HbA1c below 7%. For older and frailer patients, though, most clinical guidelines relax that target. A systematic review of 15 clinical practice guidelines found that healthier older adults were typically given targets similar to the general population, around 7% to 7.5%. For those who are frail, have multiple chronic conditions, or have a shorter life expectancy, most guidelines recommended an HbA1c at or below 8% to 8.5%, with one guideline going as high as 9%.20PubMed Central. Systematic review of guideline recommendations for older and frail adults with type 2 diabetes mellitus The rationale is straightforward: pushing blood sugar very low with aggressive medication in a frail person raises the risk of dangerous hypoglycemia, which can cause falls, confusion, and hospitalization. A slightly higher HbA1c target prioritizes safety and quality of life over the long-term complication reduction that benefits younger patients.
Lowering HbA1c Through Lifestyle
Because HbA1c reflects average blood sugar over months, it responds to sustained changes in diet, activity, and weight. A personalized program combining customized nutrition and progressive exercise in a group of people with type 2 diabetes brought the average HbA1c down from about 9.0% to 7.1%, a nearly two-point drop, with an average weight loss of about 3 kilograms.21PubMed Central. A personalized multi-interventional approach focusing on customized nutrition, progressive fitness, and lifestyle modification resulted in the reduction of HbA1c, fasting blood sugar and weight in type 2 diabetes: a retrospective study Extreme cases demonstrate how far lifestyle alone can push the number: a case report described a patient who dropped from 14.9% to 5.1% in three months through diet and exercise alone, without medication.22PubMed Central. Reduction in HbA1c through lifestyle modification in newly diagnosed type 2 diabetes mellitus patient: A great feat That is a single case and not a realistic expectation for everyone, but it illustrates the ceiling of what behavior change can accomplish, particularly in newly diagnosed individuals whose bodies still produce and respond to insulin reasonably well.
The type of exercise matters too. A head-to-head comparison found that both resistance training and aerobic treadmill exercise lowered HbA1c in people with type 2 diabetes, but resistance training produced a significantly greater reduction at the ten-week mark.23PubMed Central. Resistance exercise training lowers HbA1c more than aerobic training in adults with type 2 diabetes Building muscle mass increases the body’s capacity to store and use glucose, which helps explain why lifting weights and similar strength exercises can have an outsized effect on blood sugar control relative to their calorie burn.
Alternatives and Complements to HbA1c
HbA1c is not the only way to track long-term glucose control, and in situations where it is unreliable, alternatives step in.
Fructosamine is a blood test that measures glycated serum proteins, mainly albumin. Because albumin turns over faster than hemoglobin, fructosamine reflects blood sugar over approximately two to three weeks rather than two to three months. In a study of a Southeast Asian population, fructosamine correlated well with HbA1c, but it fills a different niche: it is useful when you need to detect changes more quickly, such as after a major medication adjustment, or in patients whose hemoglobin is unreliable due to a variant or a blood disorder.24PubMed Central. Fructosamine and HbA1c: A Correlational Study in a Southeast Asian Population
Continuous glucose monitors (CGMs) have introduced a concept called “time in range” (TIR), defined as the percentage of the day your glucose stays between 70 and 180 mg/dL. On average, spending 70% of the day in range corresponds to an HbA1c of about 7%, and each 10-percentage-point increase in TIR translates to roughly a 0.6-point drop in HbA1c.25PubMed Central. The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c But the correlation, while useful, is imperfect. A population-level study of people with type 1 diabetes found that HbA1c and TIR had a correlation of about −0.71, meaning TIR explained only about half the variation in HbA1c.26PubMed Central. Associations Between HbA1c and Glucose Time in Range Using Continuous Glucose Monitoring in Type 1 Diabetes: Cross-Sectional Population-Based Study
Why the mismatch? Part of it comes down to biology. Mean glucose explained about 63% of the variation in HbA1c in one analysis, but when researchers accounted for person-to-person differences in the relationship between glucose and glycation, that figure jumped to 88%.27PubMed Central. Discordance between mean glucose and time in range in relation to HbA(1c) in individuals with type 1 diabetes: results from the GOLD and SILVER trials In other words, some people simply glycate hemoglobin faster than others at the same blood sugar level. For about one in ten people, the discrepancy is large enough that HbA1c deviates from what their CGM data would predict by more than 0.8 percentage points. This is why many diabetes specialists now use HbA1c and CGM data together rather than treating either as the single source of truth.
Glycation Beyond Red Blood Cells
The same chemical process that produces HbA1c does not stop at hemoglobin. Glucose attaches to proteins, lipids, and even DNA throughout the body. Over time, these glycated molecules undergo further chemical reactions and cross-linking, eventually forming stable compounds called advanced glycation end-products (AGEs).28PubMed Central. Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs Unlike HbA1c, which gets cleared when old red blood cells are recycled, AGEs accumulate in tissues and are not easily removed.
AGEs matter because they are a major pathway through which chronically high blood sugar causes organ damage. They alter the structure and function of proteins in blood vessel walls, in the kidneys, and in the lens of the eye. They also bind to a cell-surface receptor called RAGE, which triggers inflammation and oxidative stress inside the cell.29PubMed Central. Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms This receptor-driven process is implicated in the progression of retinopathy, nephropathy, neuropathy, and atherosclerosis in people with diabetes.30PubMed. Advanced glycation endproducts–role in pathology of diabetic complications
Thinking about AGEs puts HbA1c in a broader context. The test is not just an arbitrary lab number; it is a surrogate for glycation happening throughout the body. When your HbA1c is high, it signals that the same sugar-protein bonding is accelerating in tissues that cannot simply be replaced the way red blood cells can. That connection between a two-month blood marker and decades-long tissue damage is ultimately what makes the test so valuable for guiding treatment decisions.
Why Cost Still Matters
HbA1c testing costs more per draw than a simple fasting plasma glucose test. For large-scale screening programs, particularly in low-resource settings, that price difference matters. A systematic review examining HbA1c as a screening tool for type 2 diabetes noted the higher per-test cost but argued that the benefits in predicting costly preventable complications could make it a cost-effective choice overall.31PubMed. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review No fasting requirement, no need for a time-sensitive sample, and a lower day-to-day variability all reduce practical barriers to getting tested. For individual patients in well-resourced health systems, cost is rarely a decisive factor. But in public health contexts where millions of screenings are at stake, the trade-off between test cost and diagnostic accuracy remains an active area of policy discussion.